Evaxion A EVAX
NASDAQ EVAX
$3.28 +0.01 (+0.31%)
At close: Sep 30, 2026 · 4:00 PM EDT

Evaxion A (EVAX) EBIT Margin (2024 - 2025)

Updated

Evaxion A's EBIT Margin was -122.66% in FY2025, up 317.89 percentage points from -440.55% in FY2024.

Analysis

Evaxion A (EVAX) EBIT Margin (2024 - 2025) Analysis & Trends

  • Per Business Quant data, EBIT Margin in earlier years was -440.55% in FY2024 (+29966.30 pp) and -30406.85% in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 28.21%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 37.86%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -3.52%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 32.97%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 20.57%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 34.95%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -133.21%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 37.40%
10 Evaxion A 21.02 Mn -45.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 40.34%
Jun 30, 2025 -11,729.73%
Dec 31, 2024 -3,298.36%
Sep 30, 2024 -57.37%
Jun 30, 2024 -2,974.68%
Mar 31, 2024 -8,619.61%
API Access

Evaxion A EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=EVAX&period=max&api_key=YOUR_API_KEY